Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Broder

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
The Lancet. Infectious Diseases|February 7, 2020
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 studyElliott Geoffrey Playford, Trent Munro, Stephen M Mahler, et al.
Plos One|October 17, 2022
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infectionMartha Sedegah, Chad Porter, Emilie Goguet, et al.
Infection Ecology & Epidemiology|May 7, 2016
The equine Hendra virus vaccine remains a highly effective preventative measure against infection in horses and humans: 'The imperative to develop a human vaccine for the Hendra virus in Australia'Alison J Peel, Hume E Field, Peter A Reid, et al.
Science (New York, N.Y.)|December 22, 2012
Comparative analysis of bat genomes provides insight into the evolution of flight and immunityGuojie Zhang, Christopher Cowled, Zhengli Shi, et al.
Frontiers in Immunology|June 28, 2021
Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild InfectionIrene Ramos, Carl Goforth, Alessandra Soares-Schanoski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2020
Nipah virus dynamics in bats and implications for spillover to humansJonathan H Epstein, Simon J Anthony, Ariful Islam, et al.
The Journal of Animal Ecology|February 2, 2026
Cohorts of immature Pteropus bats show interannual variation in Hendra virus serologyDaniel E Crowley, Caylee A Falvo, Chris K Grant, et al.
Lancet (London, England)|November 17, 2025
Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 studyRobert W Frenck, Abdi Naficy, Jodi Feser, et al.
The Lancet. Infectious Diseases|July 4, 2024
Measures to prevent and treat Nipah virus disease: research priorities for 2024-29Kristine A Moore, Angela J Mehr, Julia T Ostrowsky, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2021
Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responsesEric D Laing, Spencer L Sterling, Stephanie A Richard, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
The Lancet. Infectious Diseases|February 7, 2020
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 studyElliott Geoffrey Playford, Trent Munro, Stephen M Mahler, et al.
Plos One|October 17, 2022
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infectionMartha Sedegah, Chad Porter, Emilie Goguet, et al.
Infection Ecology & Epidemiology|May 7, 2016
The equine Hendra virus vaccine remains a highly effective preventative measure against infection in horses and humans: 'The imperative to develop a human vaccine for the Hendra virus in Australia'Alison J Peel, Hume E Field, Peter A Reid, et al.
Science (New York, N.Y.)|December 22, 2012
Comparative analysis of bat genomes provides insight into the evolution of flight and immunityGuojie Zhang, Christopher Cowled, Zhengli Shi, et al.
Frontiers in Immunology|June 28, 2021
Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild InfectionIrene Ramos, Carl Goforth, Alessandra Soares-Schanoski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2020
Nipah virus dynamics in bats and implications for spillover to humansJonathan H Epstein, Simon J Anthony, Ariful Islam, et al.
The Journal of Animal Ecology|February 2, 2026
Cohorts of immature Pteropus bats show interannual variation in Hendra virus serologyDaniel E Crowley, Caylee A Falvo, Chris K Grant, et al.
Lancet (London, England)|November 17, 2025
Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 studyRobert W Frenck, Abdi Naficy, Jodi Feser, et al.
The Lancet. Infectious Diseases|July 4, 2024
Measures to prevent and treat Nipah virus disease: research priorities for 2024-29Kristine A Moore, Angela J Mehr, Julia T Ostrowsky, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2021
Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responsesEric D Laing, Spencer L Sterling, Stephanie A Richard, et al.
Pageof 19